US National Average : $1,000-2,000 per month Our Price : very competitive Additional Costs : This treatment is nonsurgical and doesnt usually incur any extra costs
Evidence for whether GLP-1 receptor agonists can penetrate the BBB remains limited as it has been argued that brain capillary binding or sequestration may not have been accounted for [29]
This data cannot be extrapolated to compounded versions
In SURMOUNT-1 (N=2,539), tirzepatide 15 mg produced nausea in 39% of participants
These differences may reflect expectations as much as outcomes: Younger adults appear more sensitive to side effects, cost, or the friction of staying on treatment, while older adults may weigh benefits differently
Even clinicians who are not as familiar with these medications will ask me, 'I have a patient on Mounjaro who's not losing weight can we switch to Zepbound? without realizing its exactly the same drug. To complicate matters, pharmaceutical companies are quickly working on new drugs including triple agonists that target GLP-1, GIP and glucagon receptors as well as oral versions of each drug